Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Part of paid clinical trials in Aurora, Colorado.

Sponsor
AstraZeneca
Study ID
NCT07444567
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Asthma
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • Hypereosinophilic Syndrome (HES)

Eligibility Criteria

Sex
ALL
Age
6 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Benralizumab — DRUG
    Accessorized Pre-Filled Syringe (Solution for injection).

Study Details

The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and are deemed appropriate for continued benralizumab treatment, as judged by the Investigator, while monitoring long-term safety and tolerability of benralizumab.

Key Dates

First listed
Mar 3, 2026
Start date
Jul 24, 2026
Status verified
Aug 2026
Primary completion
Jan 3, 2030
Completion
Jan 3, 2030

Study Design

Enrollment
230 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Benralizumab arm
    Benralizumab will be administrated as an subcutaneous injection at a frequency in line with that received in the parent study.

Primary Outcome Measure

Safety will be evaluated by monitoring and assessing SAEs and non-serious AEs reported throughout the study and until 8 weeks after the last dose of benralizumab [ Time Frame: From baseline until 8 weeks after the last dose of benralizumab ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Research SiteAuroraColorado80045-
Research SiteBethesdaMaryland20892-
Research SiteAnn ArborMichigan48105-
Research SiteNorthfieldNew Jersey08225-
Research SiteThe BronxNew York10459-
Research SiteDurhamNorth Carolina27705-
Research SiteClevelandOhio44106-
Research SiteSalt Lake CityUtah84107-

Find similar trials in Aurora, CO

Nationwide
Asthma trialsPulmonology trialsLung disease trials
By condition
Asthma
By specialty
PulmonologyLung disease

Related Studies